If lymph node involvement is verified in a patient going through neoadjuvant therapy who is a potential prospect for specific axillary dissection (TAD), a marker ought to be inserted from the lymph node right after biopsy.This investigation or therapeutic intervention is highly useful for patients, is usually advised with no restriction, and should